Sanxin Medical announced that the company raised 24 million yuan to increase investment in Jiangxi Chengtukang Technology Co., Ltd. to implement a fund-raising project to upgrade the electron accelerator irradiation sterilization production line. After the capital increase, the company directly held 69.7291% of Jiangxi Chengtukang's shares, and still controlled 100% of its shares in total. The scope of the consolidated statement remained unchanged; Jiangxi Chengtukang's registered capital increased from 5 million yuan to 165.175.31 million yuan. Recently, Jiangxi Chengtukang completed the industrial and commercial change registration procedure for this capital increase and obtained a new business license.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.